Marker Therapeutics financial statements

마커 테라퓨틱스NASDAQ:MRKR · Nasdaq · Healthcare · sector #17
$1.04+2.97%
2026-10-07 close

Marker Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $7M. 2024 operating profit was −$11M.

Reported results

Marker Therapeutics notifications

Quantus Signal · live data · not investment advice · Privacy Policy